Valvular Heart Disease in the Community: A European Experience
Abstract
The Euro Heart Survey on valvular heart disease included 5001 patients from 92 centers in 25 European countries in 2001: 71.9% had native valve disease and 28.1% had previously undergone valve surgery. Aortic stenosis (AS) and mitral regurgitation (MR) accounted for 43.1 and 33.6%, respectively, of single-valve diseases and were mostly caused by degenerative diseases. Mean age was 69 and 65 years, respectively, and at least one comorbidity was present in 36.3% of patients with AS and 41.7% with MR. Analysis of the therapeutic decision in patients with severe valve diseases showed that symptomatic patients were frequently denied surgery (32.3% in AS after the age of 75 and 51.3% in MR), more on the basis of age and left ventricular function than comorbidities. There was a better concordance between practice and guidelines concerning interventions in asymptomatic patients. These findings underline the need for better implementation of guidelines.
To access this article, please choose from the options below
The Euro Heart Survey on valvular heart disease was funded by the European Society of Cardiology, Dutch Heart Foundation, Fédération Française de Cardiologie/Société Française de Cardiologie, Hellenic Cardiological Society, Swedish Heart and Lung Foundation, European Commission Grant (Infermed/Mansev Project), and Toray Medical Company.
PII: S0146-2806(07)00085-0
doi:10.1016/j.cpcardiol.2007.07.002
© 2007 Mosby, Inc. All rights reserved.
